Extreme prematurity-associated alterations of pulmonary inflammatory mediators before and after surfactant administration
Background: The role of prematurity and pulmonary inflammation in the pathogenesis of bronchopulmonary dysplasia (BPD) is very well-defined. However, there is limited knowledge about whether the level of prematurity and surfactant therapy alter the pulmonary cytokines and endothelial growth factor (...
Main Authors: | Rajeev Mehta, Avinash Purohit, Anna Petrova |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Pediatrics and Neonatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1875957222002091 |
Similar Items
-
Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants
by: Ji Won Koh, et al.
Published: (2018-10-01) -
Comparison of the Consequences of Intratracheal Administration of Surfactant Plus Budesonide with Surfactant alone in Preterm Infants with Respiratory Distress Syndrome
by: Morteza Habibi, et al.
Published: (2024-01-01) -
EXOGENOUS SURFACTANTS OF NATURAL ORIGIN IN THE TREATMENT OF RESPIRATORY DISTRESS SYNDROME - COMPARATIVE COMPOSITION, BIOPHYSICAL PROPERTIES AND CLINICAL EFFECTIVENESS
by: D.О. Dobryanskyy
Published: (2020-10-01) -
Use of therapeutic surfactant lavage in a preterm infant with massive pulmonary hemorrhage
by: Ino Kanavaki, et al.
Published: (2012-08-01) -
Intra-amniotic administration of exogenous pulmonary surfactant for improving in lung maturity of fetal rabbits with intrauterine infection caused by premature rupture of membranes
by: Jing Liu, et al.
Published: (2011-05-01)